跳至主要内容
临床试验/CTRI/2020/07/026520
CTRI/2020/07/026520尚未招募4 期

An open-label randomized pilot study to compare the efficacy and adverse effects of vilazodone versus escitalopram in major depression

Dr P N Suresh Kumar0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Age more than 18 and less than 65 years.
  • 2 No antidepressant and antipsychotic exposure for the past 2 months.

排除标准

  • 1 Other co-morbid psychiatric disorders.
  • 2 Pregnancy and lactation.
  • 3 Concurrent major life-threatening illness like malignancy, cardiac failure, renal failure etc.
  • 4 Suicidal patients.
  • 5 Alcohol and substance abuse and smokers.

研究者

发起方
Dr P N Suresh Kumar

相似试验